Exosome Diagnostic and Therapeutics Market to Reach USD 401.70 Million by 2032 Amid Rapid Advances in Liquid Biopsy, Precision Medicine, and Exosome-Based Drug Delivery - Credence Research...
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
Analysis, 2025 – 2032 " report has been added to the Credence Research Inc. offering. Credence Research Logo The global Exosome Diagnostic and Therapeutics Market is projected to grow from USD 41.3 Million in 2025 to an estimated USD 401.70 Million by 2032, registering an exceptional CAGR of 31.10% during the forecast period. The market's rapid expansion reflects growing demand for non-invasive diagnostic methods, rising adoption of precision medicine, and the increasing role of exosomes as promising carriers for targeted therapeutic delivery across oncology, neurology, and other disease areas. Scope & Segmentation – Exosome Diagnostic and Therapeutics Market The report provides a comprehensive analysis of the global Exosome Diagnostic and Therapeutics Market, covering revenue forecasts from 2025 to 2032 . It evaluates market drivers, trends, challenges, opportunities, competitive landscape, and regional dynamics influencing the adoption of exosome-based technologies. The stud
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Slingshot Biosciences Appoints Jim Snook as Senior Vice President, Global Sales [Yahoo! Finance]Yahoo! Finance
- Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Avoid TECH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Corporation (TECH) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Middle East DNA Synthesis Market Research Report 2026: $7.6 Bn Industry Trends and Forecasts to 2035 - Precision Medicine, Molecular Diagnostics and Biopharma R&D Investments Accelerate Demand [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 2/4/26 - Beat
TECH
Sec Filings
- 3/4/26 - Form 3
- 3/4/26 - Form 4
- 2/19/26 - Form 4
- TECH's page on the SEC website